{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-036150","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.775416+00:00","generated_at":"2026-05-31T10:57:07.902210+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Joint Corp Q2 net loss $3.6M ($0.24/sh); revenue $30.3M up 3% YoY; guidance reaffirmed","bullets":["Net loss $3.6M ($0.24 loss per share) vs net loss $320K ($0.02 loss) in Q2 2023.","Revenue $30.3M +3% YoY; system-wide sales $129.6M +8%; comp sales +2%.","Adjusted EBITDA $2.1M vs $3.2M; includes $1.5M litigation expense and $1.4M impairment.","Sold 7 franchise licenses (vs 21); total clinics 960; over 10 refranchise LOIs in progress.","2024 guidance reiterated: system-wide sales $530-545M, mid-single digit comps, 60-75 new clinics."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-036150","json":"https://secwatch.observer/filing/0001628280-24-036150.json","markdown":"https://secwatch.observer/filing/0001628280-24-036150.md","text":"https://secwatch.observer/filing/0001628280-24-036150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/0001628280-24-036150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/jynt-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:57:07.902210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}